Illumina | ILMN - Sales Revenues


Illumina reported $1.16B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Agilent USD 1.8B 63M Dec/2025
Bio Techne USD 295.9M 9.34M Dec/2025
Bio-Rad Laboratories USD 693.2M 40.2M Dec/2025
Boston Scientific USD 5.29B 220M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Danaher USD 6.84B 790M Dec/2025
Dentsply International USD 904M 32M Sep/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Exact Sciences USD 878.38M 27.38M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Illumina USD 1.16B 80M Dec/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
Laboratory Of America USD 3.52B 40M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Myriad Genetics USD 209.8M 4.1M Dec/2025
OraSure Technologies USD 39.92M 14.42M Sep/2024
Pacific Biosciences Of California USD 39.97M 3.95M Sep/2024
Quest Diagnostics USD 2.81B 10M Dec/2025
Quidel USD 724M 24M Dec/2025
Repligen USD 197.91M 8.91M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Standard Biotools USD 19.55M 2.21M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Waters USD 932M 132M Dec/2025